# Docfy — Quality Principles

**Version:** 0.1  
**Status:** Active

Quality in Docfy is treated as a shared engineering responsibility that begins before implementation and continues throughout the product lifecycle.

These principles guide product decisions, development practices, testing strategies and release decisions.

---

## 1. Quality is a shared responsibility

Quality is not owned exclusively by QA.

Product, Development and Quality Engineering collaborate to prevent defects, improve testability and make quality visible throughout delivery.

---

## 2. Quality starts before implementation

Quality activities begin during product discovery and requirement definition.

Before development starts, the team should evaluate:

- business rules;
- acceptance criteria;
- risks;
- dependencies;
- testability;
- usability;
- accessibility;
- observability.

---

## 3. Testing is risk-driven

Testing effort should be proportional to product risk.

Higher-risk functionality should receive deeper coverage across appropriate testing layers.

Risk analysis considers factors such as:

- business impact;
- probability of failure;
- user impact;
- security impact;
- data integrity;
- operational impact.

---

## 4. Automation is a means, not the goal

Automation exists to provide fast, reliable and repeatable feedback.

Not every test should be automated.

Automation should prioritize:

- critical business rules;
- regression-prone functionality;
- repetitive validation;
- API contracts;
- critical user journeys;
- quality gates.

Exploratory testing, usability evaluation and other human-centered activities remain essential.

---

## 5. Testability is a product requirement

The product should be designed so that its behavior can be reliably observed, controlled and validated.

Examples include:

- stable semantic identifiers;
- deterministic test data;
- structured API errors;
- health checks;
- structured logs;
- correlation IDs;
- controlled failure simulation.

---

## 6. Shift quality left

Defects should be prevented as early as possible.

Quality Engineering should contribute during:

- requirement analysis;
- refinement;
- architecture discussions;
- development;
- code review;
- CI/CD;
- release evaluation.

---

## 7. Accessibility and usability are quality requirements

A feature is not considered high quality only because it works technically.

The product must also be understandable, usable and accessible.

Accessibility and usability should therefore be evaluated throughout product development.

---

## 8. Quality must be observable

Test results should generate actionable information.

Quality indicators may include:

- automated test results;
- escaped defects;
- flaky test rate;
- pipeline stability;
- performance indicators;
- accessibility findings;
- usability findings;
- production incidents.

Metrics should support decisions rather than exist only for reporting.

---

## 9. Failures should generate learning

Defects and production incidents should be treated as opportunities to improve the system and the quality process.

Relevant failures should lead to:

1. investigation;
2. root cause analysis;
3. corrective action;
4. preventive action;
5. additional coverage when appropriate.

---

## 10. AI assists; humans decide

Artificial Intelligence may support Quality Engineering activities such as:

- requirement analysis;
- risk brainstorming;
- test idea generation;
- synthetic test data generation;
- failure clustering;
- log analysis;
- exploratory testing preparation.

AI-generated outputs must be reviewed and validated by a human.

AI suggestions are hypotheses, not evidence.

Sensitive information, credentials and real customer data must never be exposed to unauthorized AI services.

---

## 11. Quality decisions should be evidence-based

Release decisions should consider multiple signals instead of relying only on test pass rates.

Relevant evidence may include:

- functional coverage;
- remaining risks;
- automated test results;
- exploratory testing findings;
- performance results;
- accessibility findings;
- known defects;
- production readiness.

The goal is not to prove that the product has no defects.

The goal is to understand the remaining risk well enough to make an informed decision.